Article

Segment 4 - Biomarkers in Bone Turnover and Immunoglobulin Expression

Dr Chernew leads the conversation to biomarkers in bone turnover and immunoglobulin expression.

Dr Chernew leads the conversation to biomarkers in bone turnover and immunoglobulin expression. Dr Kumar says the use of biomarkers can be very specific to a disease type. He analyzes the use of bone marrow and bone biomarkers for monitoring myeloma bone disease. He says there are both prognostic and predictive biomarkers which suit different purposes. There are also other emerging biomarkers that are being studied and explored.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
David Awad, PharmD, BCOP
Coral Omene, MD, PhD, sitting for a vieo interview
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Coral Omene, MD, PhD, sitting for a vieo interview
David Awad, PharmD, BCOP
Screenshot of Coral Omene, MD, PhD
ASCO 2025
Constance Blunt, MD, medical oncologist, Mary Bird Perkins Cancer Center
Cathy Eng, MD, FACP, FASCO
Nini Wu, MD, Navista
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo